• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular Cloning and Functional Analysis of CDK Variant Expressed in Breast Cancer Tissues

Research Project

Project/Area Number 09671263
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field General surgery
Research InstitutionSt.Marianna University School of Medicine

Principal Investigator

FUKUDA Mamoru  St.Marianna University School of Medicine, Department of Surgery, Associate Professor, 医学部, 助教授 (50081724)

Co-Investigator(Kenkyū-buntansha) OGATA Haruki  St.Marianna University School of Medicine, Department of Surgery, Instructor, 医学部, 助手 (60267581)
OHTA Tomohiko  St.Marianna University School of Medicine, Department of Surgery, Assistant Professor, 医学部, 講師 (60233136)
Project Period (FY) 1997 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥2,800,000 (Direct Cost: ¥2,800,000)
Fiscal Year 1999: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1998: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1997: ¥1,300,000 (Direct Cost: ¥1,300,000)
Keywordsbreast cancer / cell cycle / CDC2ΔT / CDK2ΔT / variant / T-loop / CDK2ΔT / cdc2 / cdk2 / p21 / Δcdc2 / Δcdk2 / RT-PCR
Research Abstract

We have cloned a T-loop deletion variant CDC2(CDC2ΔT : described as ΔCDC2 in the application form for this grant) from breast cancer tissues, and investigated its function and the possibility of similar variant in other CDK family. CDC2ΔT-HA was transiently co-expressed in Hela cells with cyclin B1 and/or 21 CDK inhibitor. The protein-protein interaction was studied by ィイD135ィエD1S-immunoprecipitation(IP) or IP-western, and kianse activity of the immunocomplex was studied by Histo-H1 kinase assay. Although CDC2ΔT possesses the conserved cyclin binding site and the ATP binding site, it is unable to complex with either Cyclin B1 nor p21 and lacks histon H1 kinase activity. The results indicate that the T-loop not only play a key role in keeping a free CDK in its inactive state but also in facilitating CDK activation by promoting cyclin binding. Through additional study to investigate other variant in CDK family, we cloned a CDK2 variant, which lacks 34 amino acids in the C-terminal portion of its T-loop. (CDK2ΔT, #AB012305) The biological significance of these variants in cell cycle or carcinogenesis is unclear at present. Further investigation of detail function of each domain of CDC2 and CDK2 may elacidate the role of these variants.

Report

(4 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • 1997 Annual Research Report
  • Research Products

    (15 results)

All Other

All Publications (15 results)

  • [Publications] Ohta T. et al: "T-loop deletion of CDC2 from breast cancer tissues eliminates binding tocyclin Bland cycli-dependent kinasa inhibitor"cancer Res.. 58. 1095-1098 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] 西川徹 他: "乳癌よりクローニングされたT-loop部分欠損型CDK2 variant"聖マリアンナ医科大学雑誌. 26. 359-366 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ohta T., Okamoto K., Isohashi F., Shibata K., Fukuda M., Yamaguchi S., Xiong Y.: "T-loop deletion of CDC2 from breast cancer tissues eliminates binding to cyclin B1 and cyclin-dependent kinase inhibitor p21."Cancer Res.. 58. 1095-1098 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ohta T. et al: "T-loop deletion of CDC2 from breast cancer tissues eliminates binding tocyclin Bland cycli-dependent kinasa inhibitor"canser Res.. 58. 1095-1098 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] 西川 徹 他: "乳癌よりクローニングされたT-loop 部分欠損型 CDK2 variant"聖マリアンナ医科大学雑誌. 26. 359-366 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] 福田 護 他: "乳房円状部分切除の要点" 臨床外科. 54(1). 37-41 (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] 今村恵子 福田 護 他: "マンモグラフィの精度管理のためのファントム画像データベース -第2報デジタル化とACRファントムの諸問題-" 日本乳癌検診学会雑誌. 7(1). 103-112 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Tomohiko Ohta Mamoru Fukuda et al: "T-Loop Deletion of CDC2 from Breast Cancer Tissues Eliminates Binding to Cyclin B1 and Cyclin-dependent Kinase Inhibitor p21." Cancer Research. 58. 1095-1098 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 福田 護: "乳管造影法" Knack&Pitfalls 乳腺外科の要点と盲点. 260-261 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 山本 浩 福田 護 他: "乳がんUICCTNM分類(1997)の問題点" 癌と化学療法. 25(7). 1087-1093 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 福田護: "川崎市におけるマンモグラフィ精度管理システム構築の検討" 厚生省がん研究助成金平成8年度報告. (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] 福田護: "川崎市乳癌検診参加施設のマンモグラフィの精度の検討" 日本乳癌検診学会誌. 6・2. 167-174 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] 今村恵子: "マンモグラフィの精度管理のためのファントム画像データベース" 日本乳癌検診学会誌. 6・2. 271-279 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] 大内憲明: "マンモグラフィ導入による乳癌検診の問題点と対策" 日本乳癌検診学会誌. 6・2. 137-143 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] T.Ohta: "Analysis of cdc2 and Cyclin D1 Expression in Breast Cancer by immunoblotting" J.Jpn Breast Cancer Soc.Vol.4,No.1. 17-24 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi